Study Data


Go back (Print Records)

NMR Study

Project uploaded by: Upasna
Project ID: IMP_100033
Title: Characterizing Metabolic Dysregulation in Early-Stage Chronic Kidney Disease for Diagnostic Insight
Project Description: Chronic kidney disease (CKD) is a progressive condition that can be difficult to diagnose in its early stages, as conventional diagnostic methods such as serum creatinine and albumin assessments are often insufficient. Early-stage CKD (Stages G1-G3), defined by a glomerular filtration rate (GFR) of ≥30 mL/min/1.73 m², typically reflects normal to moderately reduced kidney function, often without overt symptoms. This study aims to address the gap in early CKD diagnosis by identifying metabolic alterations and potential biomarkers that could enable earlier detection and personalized treatment strategies. To investigate specific metabolic changes associated with early CKD, we performed a comprehensive metabolomic analysis of 115 human serum samples, including 24 healthy controls and 91 patients with early-stage CKD, using 1H nuclear magnetic resonance (NMR). Data preprocessing and statistical analyses, including principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), orthogonal PLS-DA (OPLS-DA), ANOVA, and Student's t-test, were conducted using MetaboAnalyst 6.0. Random forest modeling demonstrated strong differentiation between CKD stages. The diagnostic potential of the differentially regulated metabolites was assessed using Receiver Operating Characteristic (ROC) analysis, and metabolic pathway enrichment was conducted using the KEGG database. We identified significant alterations in ten metabolites across CKD stages: myo-inositol, glycerol, pyruvate, carnitine, phenylalanine, tyrosine, histidine, TMAO, 2-hydroxyisobutyrate, and 3-hydroxyisobutyrate (p < 0.05, VIP > 1). ROC analysis revealed area under the curve (AUC) values greater than 0.7, indicating promising diagnostic value for these metabolites. Pathway analysis highlighted significant dysregulation in the metabolism of inositol phosphate, tyrosine, histidine, pyruvate, and the biosynthesis of phenylalanine, tryptophan, and tyrosine. This study provides a detailed overview of the metabolic disturbances associated with early-stage CKD and identifies potential biomarkers for early detection. These findings could contribute to the development of personalized therapeutic approaches for the early management of CKD.
Research Area: Biological Sciences
Funding Source: University Grants Commission
Project Contributors: Upasna Gupta, Amrita Sahu, Dharmendra Singh Bhadauria, Bikash Baishya and Neeraj Sinha

Study uploaded by: Upasna
Study ID: IMS_100027
Title: Characterizing Metabolic Dysregulation in Early-Stage Chronic Kidney Disease for Diagnostic Insight
Summary: Chronic kidney disease (CKD) is a progressive condition that can be difficult to diagnose in its early stages, especially using conventional methods such as serum creatinine and albumin tests. Early-stage CKD (Stages G1-G3) is defined by a glomerular filtration rate (GFR) of ≥30 mL/min/1.73 m², which reflects normal to moderately reduced kidney function, often without overt symptoms. The aim of this study was to identify specific metabolic alterations and potential biomarkers for early-stage CKD detection, addressing a gap in the current understanding of CKD pathophysiology. To explore metabolic changes associated with early CKD, the study analyzed 115 human serum samples using ^1H nuclear magnetic resonance (NMR) spectroscopy. The samples included 24 healthy controls and 91 patients with early-stage CKD. Comprehensive data preprocessing and statistical analyses were performed using MetaboAnalyst 6.0, which included techniques like principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), orthogonal PLS-DA (OPLS-DA), ANOVA, and Student's t-test. Random forest modeling was used to assess the ability of the metabolites to differentiate between CKD stages. The diagnostic potential of the metabolites was further evaluated using Receiver Operating Characteristic (ROC) analysis, and pathway enrichment analysis was conducted using the KEGG database. The analysis revealed significant changes in the concentrations of ten metabolites across CKD stages. These metabolites included myo-inositol, glycerol, pyruvate, carnitine, phenylalanine, tyrosine, histidine, TMAO, 2-hydroxyisobutyrate, and 3-hydroxyisobutyrate. Statistical significance was confirmed for these metabolites (p < 0.05, VIP > 1). ROC curve analysis showed area under the curve (AUC) values greater than 0.7 for these metabolites, indicating their potential for use as diagnostic biomarkers. Pathway enrichment analysis revealed significant dysregulation in several metabolic pathways, including those related to inositol phosphate metabolism, tyrosine and histidine metabolism, pyruvate metabolism, and the biosynthesis of phenylalanine, tryptophan, and tyrosine. This comprehensive metabolomic study highlights several key metabolic alterations in early-stage CKD that could serve as biomarkers for the disease. The findings suggest that changes in metabolic pathways involving amino acids, phospholipids, and other metabolites could be valuable indicators of early kidney dysfunction. By identifying these biomarkers, the study contributes to the growing body of research aimed at improving early detection and personalized treatment strategies for CKD. Furthermore, these biomarkers could assist in monitoring disease progression and tailoring interventions to individual patient needs. In conclusion, the results of this study offer valuable insights into the metabolic disturbances associated with early-stage CKD. The identified biomarkers have the potential to enhance diagnostic accuracy and facilitate earlier, more personalized management of CKD. These findings underscore the importance of metabolomics as a tool for advancing our understanding of CKD and improving patient outcomes through targeted, individualized therapies.
Keywords: Chronic Kidney Disease (CKD), Metabolomics, serum, Nuclear Magnetic Resonance (NMR), Biomarkers, Personalised treatment plan
Publication:
Release Date: May 30, 2025
Study Type: Nuclear Magnetic Resonance (NMR)
Data Type: Untargeted
IEC/IBSC Approval Number : (2023-203-PhD-133)

Sr.No Sample ID Sample Name Organism Source Sample Preparation Protocol Sample Type Experimental Condition Time of treatment Variant/Variety Gender Age Replicates Storage Conditions Extraction Protocol Number of files per sample
1 IMSM_101327 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
2 IMSM_101328 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
3 IMSM_101329 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
4 IMSM_101330 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
5 IMSM_101331 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
6 IMSM_101332 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
7 IMSM_101333 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
8 IMSM_101334 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
9 IMSM_101335 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
10 IMSM_101336 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
11 IMSM_101337 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
12 IMSM_101338 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
13 IMSM_101339 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
14 IMSM_101340 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
15 IMSM_101341 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
16 IMSM_101342 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
17 IMSM_101343 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
18 IMSM_101344 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
19 IMSM_101345 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
20 IMSM_101346 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
21 IMSM_101347 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
22 IMSM_101348 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
23 IMSM_101349 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
24 IMSM_101350 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
25 IMSM_101351 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
26 IMSM_101352 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
27 IMSM_101353 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
28 IMSM_101354 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
29 IMSM_101355 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
30 IMSM_101356 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
31 IMSM_101357 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
32 IMSM_101358 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
33 IMSM_101359 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
34 IMSM_101360 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
35 IMSM_101361 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
36 IMSM_101362 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
37 IMSM_101363 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
38 IMSM_101364 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
39 IMSM_101365 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
40 IMSM_101366 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
41 IMSM_101367 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
42 IMSM_101368 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
43 IMSM_101369 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
44 IMSM_101370 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
45 IMSM_101371 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
46 IMSM_101372 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
47 IMSM_101373 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
48 IMSM_101374 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
49 IMSM_101375 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
50 IMSM_101376 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
51 IMSM_101377 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
52 IMSM_101378 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
53 IMSM_101379 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
54 IMSM_101380 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
55 IMSM_101381 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
56 IMSM_101382 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
57 IMSM_101383 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
58 IMSM_101384 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
59 IMSM_101385 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
60 IMSM_101386 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
61 IMSM_101387 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
62 IMSM_101388 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
63 IMSM_101389 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
64 IMSM_101390 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
65 IMSM_101391 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
66 IMSM_101392 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
67 IMSM_101393 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
68 IMSM_101394 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
69 IMSM_101395 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
70 IMSM_101396 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
71 IMSM_101397 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
72 IMSM_101398 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
73 IMSM_101399 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
74 IMSM_101400 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
75 IMSM_101401 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
76 IMSM_101402 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
77 IMSM_101403 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
78 IMSM_101404 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
79 IMSM_101405 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
80 IMSM_101406 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
81 IMSM_101407 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
82 IMSM_101408 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
83 IMSM_101409 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
84 IMSM_101410 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
85 IMSM_101411 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
86 IMSM_101412 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
87 IMSM_101413 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
88 IMSM_101414 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
89 IMSM_101415 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
90 IMSM_101416 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
91 IMSM_101417 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
92 IMSM_101418 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
93 IMSM_101419 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
94 IMSM_101420 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
95 IMSM_101421 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
96 IMSM_101422 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
97 IMSM_101423 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
98 IMSM_101424 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
99 IMSM_101425 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
100 IMSM_101426 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
101 IMSM_101427 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
102 IMSM_101428 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
103 IMSM_101429 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
104 IMSM_101430 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
105 IMSM_101431 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
106 IMSM_101432 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
107 IMSM_101433 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
108 IMSM_101434 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
109 IMSM_101435 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
110 IMSM_101436 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
111 IMSM_101437 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
112 IMSM_101438 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
113 IMSM_101439 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
114 IMSM_101440 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.
115 IMSM_101441 Human Blood Homo sapiens Blood Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). Serum Untreated NA NA NA NA NA 80C

Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis.

Sr.No NMR Exp ID Sample Name/ID Reference Standard NMR Instrument Name NMR Instrument Type NMR Experiment Type NMR Spectrometer Frequency NMR Probe NMR Probe temperature NMR Solvent NMR tube size Data Transformation (Software/s Used)
1 IME_100572 Human Blood / IMSM_101327 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
2 IME_100573 Human Blood / IMSM_101328 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
3 IME_100574 Human Blood / IMSM_101329 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
4 IME_100575 Human Blood / IMSM_101330 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
5 IME_100576 Human Blood / IMSM_101331 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
6 IME_100577 Human Blood / IMSM_101332 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
7 IME_100578 Human Blood / IMSM_101333 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
8 IME_100579 Human Blood / IMSM_101334 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
9 IME_100580 Human Blood / IMSM_101335 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
10 IME_100581 Human Blood / IMSM_101336 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
11 IME_100582 Human Blood / IMSM_101337 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
12 IME_100583 Human Blood / IMSM_101338 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
13 IME_100584 Human Blood / IMSM_101339 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
14 IME_100585 Human Blood / IMSM_101340 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
15 IME_100586 Human Blood / IMSM_101341 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
16 IME_100587 Human Blood / IMSM_101342 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
17 IME_100588 Human Blood / IMSM_101343 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
18 IME_100589 Human Blood / IMSM_101344 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
19 IME_100590 Human Blood / IMSM_101345 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
20 IME_100591 Human Blood / IMSM_101346 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
21 IME_100592 Human Blood / IMSM_101347 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
22 IME_100593 Human Blood / IMSM_101348 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
23 IME_100594 Human Blood / IMSM_101349 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
24 IME_100595 Human Blood / IMSM_101350 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
25 IME_100596 Human Blood / IMSM_101351 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
26 IME_100597 Human Blood / IMSM_101352 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
27 IME_100598 Human Blood / IMSM_101353 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
28 IME_100599 Human Blood / IMSM_101354 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
29 IME_100600 Human Blood / IMSM_101355 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
30 IME_100601 Human Blood / IMSM_101356 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
31 IME_100602 Human Blood / IMSM_101357 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
32 IME_100603 Human Blood / IMSM_101358 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
33 IME_100604 Human Blood / IMSM_101359 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
34 IME_100605 Human Blood / IMSM_101360 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
35 IME_100606 Human Blood / IMSM_101361 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
36 IME_100607 Human Blood / IMSM_101362 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
37 IME_100608 Human Blood / IMSM_101363 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
38 IME_100609 Human Blood / IMSM_101364 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
39 IME_100610 Human Blood / IMSM_101365 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
40 IME_100611 Human Blood / IMSM_101366 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
41 IME_100612 Human Blood / IMSM_101367 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
42 IME_100613 Human Blood / IMSM_101368 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
43 IME_100614 Human Blood / IMSM_101369 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
44 IME_100615 Human Blood / IMSM_101370 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
45 IME_100616 Human Blood / IMSM_101371 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
46 IME_100617 Human Blood / IMSM_101372 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
47 IME_100618 Human Blood / IMSM_101373 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
48 IME_100619 Human Blood / IMSM_101374 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
49 IME_100620 Human Blood / IMSM_101375 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
50 IME_100621 Human Blood / IMSM_101376 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
51 IME_100622 Human Blood / IMSM_101377 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
52 IME_100623 Human Blood / IMSM_101378 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
53 IME_100624 Human Blood / IMSM_101379 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
54 IME_100625 Human Blood / IMSM_101380 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
55 IME_100626 Human Blood / IMSM_101381 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
56 IME_100627 Human Blood / IMSM_101382 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
57 IME_100628 Human Blood / IMSM_101383 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
58 IME_100629 Human Blood / IMSM_101384 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
59 IME_100630 Human Blood / IMSM_101385 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
60 IME_100631 Human Blood / IMSM_101386 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
61 IME_100632 Human Blood / IMSM_101387 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
62 IME_100633 Human Blood / IMSM_101388 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
63 IME_100634 Human Blood / IMSM_101389 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
64 IME_100635 Human Blood / IMSM_101390 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
65 IME_100636 Human Blood / IMSM_101391 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
66 IME_100637 Human Blood / IMSM_101392 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
67 IME_100638 Human Blood / IMSM_101393 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
68 IME_100639 Human Blood / IMSM_101394 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
69 IME_100640 Human Blood / IMSM_101395 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
70 IME_100641 Human Blood / IMSM_101396 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
71 IME_100642 Human Blood / IMSM_101397 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
72 IME_100643 Human Blood / IMSM_101398 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
73 IME_100644 Human Blood / IMSM_101399 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
74 IME_100645 Human Blood / IMSM_101400 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
75 IME_100646 Human Blood / IMSM_101401 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
76 IME_100647 Human Blood / IMSM_101402 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
77 IME_100648 Human Blood / IMSM_101403 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
78 IME_100649 Human Blood / IMSM_101404 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
79 IME_100650 Human Blood / IMSM_101405 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
80 IME_100651 Human Blood / IMSM_101406 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
81 IME_100652 Human Blood / IMSM_101407 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
82 IME_100653 Human Blood / IMSM_101408 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
83 IME_100654 Human Blood / IMSM_101409 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
84 IME_100655 Human Blood / IMSM_101410 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
85 IME_100656 Human Blood / IMSM_101411 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
86 IME_100657 Human Blood / IMSM_101412 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
87 IME_100658 Human Blood / IMSM_101413 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
88 IME_100659 Human Blood / IMSM_101414 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
89 IME_100660 Human Blood / IMSM_101415 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
90 IME_100661 Human Blood / IMSM_101416 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
91 IME_100662 Human Blood / IMSM_101417 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
92 IME_100663 Human Blood / IMSM_101418 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
93 IME_100664 Human Blood / IMSM_101419 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
94 IME_100665 Human Blood / IMSM_101420 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
95 IME_100666 Human Blood / IMSM_101421 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
96 IME_100667 Human Blood / IMSM_101422 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
97 IME_100668 Human Blood / IMSM_101423 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
98 IME_100669 Human Blood / IMSM_101424 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
99 IME_100670 Human Blood / IMSM_101425 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
100 IME_100671 Human Blood / IMSM_101426 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
101 IME_100672 Human Blood / IMSM_101427 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
102 IME_100673 Human Blood / IMSM_101428 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
103 IME_100674 Human Blood / IMSM_101429 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
104 IME_100675 Human Blood / IMSM_101430 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
105 IME_100676 Human Blood / IMSM_101431 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
106 IME_100677 Human Blood / IMSM_101432 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
107 IME_100678 Human Blood / IMSM_101433 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
108 IME_100679 Human Blood / IMSM_101434 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
109 IME_100680 Human Blood / IMSM_101435 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
110 IME_100681 Human Blood / IMSM_101436 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
111 IME_100682 Human Blood / IMSM_101437 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
112 IME_100683 Human Blood / IMSM_101438 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
113 IME_100684 Human Blood / IMSM_101439 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
114 IME_100685 Human Blood / IMSM_101440 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin
115 IME_100686 Human Blood / IMSM_101441 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 Solution-State NMR 1D 1H 800 MHz Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298K D2O 5 mm Topspin

Sr.No First name Last name Email Organization Designation
1 Neeraj Sinha neerajcbmr@gmail.com Centre of Biomedical Research(CBMR), Lucknow principal_investigator
2 Bikash Baishya bikash2baishya@gmail.com Centre of Biomedical Research(CBMR), Lucknow principal_investigator
3 Dharmendra Singh Bhadauria docdharm10@gmail.com Centre of Biomedical Research(CBMR), Lucknow principal_investigator
4 Amrita Sahu sahuamrita456@gmail.com Centre of Biomedical Research(CBMR), Lucknow research_scholar
5 Upasna Gupta upasnagupta941@gmail.com Centre of Biomedical Research(CBMR), Lucknow research_scholar

Sr.No ftprun ID NMR Exp ID NMR Data Files
1 IMR_101171 IME_100572 1.zip
2 IMR_101172 IME_100573 3.zip
3 IMR_101173 IME_100574 5.zip
4 IMR_101174 IME_100575 7.zip
5 IMR_101175 IME_100576 9.zip
6 IMR_101176 IME_100577 11.zip
7 IMR_101177 IME_100578 13.zip
8 IMR_101178 IME_100579 18.zip
9 IMR_101179 IME_100580 20.zip
10 IMR_101180 IME_100581 22.zip
11 IMR_101181 IME_100582 24.zip
12 IMR_101182 IME_100583 26.zip
13 IMR_101183 IME_100584 31.zip
14 IMR_101184 IME_100585 33.zip
15 IMR_101185 IME_100586 35.zip
16 IMR_101186 IME_100587 36.zip
17 IMR_101187 IME_100588 37.zip
18 IMR_101188 IME_100589 39.zip
19 IMR_101189 IME_100590 40.zip
20 IMR_101190 IME_100591 41.zip
21 IMR_101191 IME_100592 42.zip
22 IMR_101192 IME_100593 43.zip
23 IMR_101193 IME_100594 44.zip
24 IMR_101194 IME_100595 46.zip
25 IMR_101195 IME_100596 213.zip
26 IMR_101196 IME_100597 217.zip
27 IMR_101197 IME_100598 219.zip
28 IMR_101198 IME_100599 221.zip
29 IMR_101199 IME_100600 223.zip
30 IMR_101200 IME_100601 225.zip
31 IMR_101201 IME_100602 227.zip
32 IMR_101202 IME_100603 229.zip
33 IMR_101203 IME_100604 231.zip
34 IMR_101204 IME_100605 233.zip
35 IMR_101205 IME_100606 235.zip
36 IMR_101206 IME_100607 237.zip
37 IMR_101207 IME_100608 239.zip
38 IMR_101208 IME_100609 241.zip
39 IMR_101209 IME_100610 243.zip
40 IMR_101210 IME_100611 245.zip
41 IMR_101211 IME_100612 247.zip
42 IMR_101212 IME_100613 249.zip
43 IMR_101213 IME_100614 251.zip
44 IMR_101214 IME_100615 253.zip
45 IMR_101215 IME_100616 255.zip
46 IMR_101216 IME_100617 257.zip
47 IMR_101217 IME_100618 259.zip
48 IMR_101218 IME_100619 261.zip
49 IMR_101219 IME_100620 263.zip
50 IMR_101220 IME_100621 265.zip
51 IMR_101221 IME_100622 267.zip
52 IMR_101222 IME_100623 269.zip
53 IMR_101223 IME_100624 271.zip
54 IMR_101224 IME_100625 273.zip
55 IMR_101225 IME_100626 275.zip
56 IMR_101226 IME_100627 277.zip
57 IMR_101227 IME_100628 279.zip
58 IMR_101228 IME_100629 281.zip
59 IMR_101229 IME_100630 283.zip
60 IMR_101230 IME_100631 285.zip
61 IMR_101231 IME_100632 287.zip
62 IMR_101232 IME_100633 289.zip
63 IMR_101233 IME_100634 291.zip
64 IMR_101234 IME_100635 293.zip
65 IMR_101235 IME_100636 295.zip
66 IMR_101236 IME_100637 297.zip
67 IMR_101237 IME_100638 299.zip
68 IMR_101238 IME_100639 301.zip
69 IMR_101239 IME_100640 303.zip
70 IMR_101240 IME_100641 305.zip
71 IMR_101241 IME_100642 307.zip
72 IMR_101242 IME_100643 309.zip
73 IMR_101243 IME_100644 311.zip
74 IMR_101244 IME_100645 328.zip
75 IMR_101245 IME_100646 330.zip
76 IMR_101246 IME_100647 332.zip
77 IMR_101247 IME_100648 334.zip
78 IMR_101248 IME_100649 336.zip
79 IMR_101249 IME_100650 338.zip
80 IMR_101250 IME_100651 340.zip
81 IMR_101251 IME_100652 342.zip
82 IMR_101252 IME_100653 344.zip
83 IMR_101253 IME_100654 346.zip
84 IMR_101254 IME_100655 348.zip
85 IMR_101255 IME_100656 350.zip
86 IMR_101256 IME_100657 382.zip
87 IMR_101257 IME_100658 384.zip
88 IMR_101258 IME_100659 386.zip
89 IMR_101259 IME_100660 388.zip
90 IMR_101260 IME_100661 390.zip
91 IMR_101261 IME_100662 392.zip
92 IMR_101262 IME_100663 394.zip
93 IMR_101263 IME_100664 401.zip
94 IMR_101264 IME_100665 420.zip
95 IMR_101265 IME_100666 421.zip
96 IMR_101266 IME_100667 422.zip
97 IMR_101267 IME_100668 423.zip
98 IMR_101268 IME_100669 424.zip
99 IMR_101269 IME_100670 425.zip
100 IMR_101270 IME_100671 427.zip
101 IMR_101271 IME_100672 428.zip
102 IMR_101272 IME_100673 429.zip
103 IMR_101273 IME_100674 434.zip
104 IMR_101274 IME_100675 435.zip
105 IMR_101275 IME_100676 436.zip
106 IMR_101276 IME_100677 437.zip
107 IMR_101277 IME_100678 438.zip
108 IMR_101278 IME_100679 439.zip
109 IMR_101279 IME_100680 440.zip
110 IMR_101280 IME_100681 445.zip
111 IMR_101281 IME_100682 446.zip
112 IMR_101282 IME_100683 447.zip
113 IMR_101283 IME_100684 448.zip
114 IMR_101284 IME_100685 449.zip
115 IMR_101285 IME_100686 450.zip

Download Metabolite/Compound

Sr.No Structure Details
1 Molecular Structure

2-Hydroxybutyrate

CHEBI ID: CHEBI:50613

PubChem ID: 440864

Chemical Formula: C4H8O3

Smiles: CC[C@@H](C(=O)O)O

InChI: InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
2 Molecular Structure

2-Hydroxyisobutyrate

CHEBI ID: CHEBI:19641

PubChem ID: 4277439

Chemical Formula: C4H7O3-

Smiles: CC(C)(C(=O)[O-])O

InChI: InChI=1S/C4H8O3/c1-4(2,7)3(5)6/h7H,1-2H3,(H,5,6)/p-1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
3 Molecular Structure

2-Hydroxyisovalerate

CHEBI ID: CHEBI:60645

PubChem ID: 99823

Chemical Formula: C5H10O3

Smiles: CC(C)C(C(=O)O)O

InChI: InChI=1S/C5H10O3/c1-3(2)4(6)5(7)8/h3-4,6H,1-2H3,(H,7,8)

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
4 Molecular Structure

3-Hydroxybutyrate

CHEBI ID: CHEBI:37054

PubChem ID: 3541112

Chemical Formula: C4H7O3-

Smiles: CC(CC(=O)[O-])O

InChI: InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/p-1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
5 Molecular Structure

3-Hydroxyisobutyrate

CHEBI ID: CHEBI:11805

PubChem ID: 11966314

Chemical Formula: C4H7O3-

Smiles: CC(CO)C(=O)[O-]

InChI: InChI=1S/C4H8O3/c1-3(2-5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/p-1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
6 Molecular Structure

3-Hydroxyisovalerate

CHEBI ID: CHEBI:82957

PubChem ID: 6950804

Chemical Formula: C5H9O3-

Smiles: CC(C)(CC(=O)[O-])O

InChI: InChI=1S/C5H10O3/c1-5(2,8)3-4(6)7/h8H,3H2,1-2H3,(H,6,7)/p-1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
7 Molecular Structure

Acetate

CHEBI ID: CHEBI:30089

PubChem ID: 175

Chemical Formula: C2H3O2-

Smiles: CC(=O)[O-]

InChI: InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)/p-1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
8 Molecular Structure

Acetoacetate

CHEBI ID: CHEBI:13705

PubChem ID: 6971017

Chemical Formula: C4H5O3-

Smiles: CC(=O)CC(=O)[O-]

InChI: InChI=1S/C4H6O3/c1-3(5)2-4(6)7/h2H2,1H3,(H,6,7)/p-1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
9 Molecular Structure

Acetone

CHEBI ID: CHEBI:15347

PubChem ID: 180

Chemical Formula: C3H6O

Smiles: CC(=O)C

InChI: InChI=1S/C3H6O/c1-3(2)4/h1-2H3

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
10 Molecular Structure

Alanine

CHEBI ID: CHEBI:16977

PubChem ID: 5950

Chemical Formula: C3H7NO2

Smiles: C[C@@H](C(=O)O)N

InChI: InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
11 Molecular Structure

Arginine

CHEBI ID: CHEBI:16467

PubChem ID: 6322

Chemical Formula: C6H14N4O2

Smiles: C(C[C@@H](C(=O)O)N)CN=C(N)N

InChI: InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
12 Molecular Structure

Asparagine

CHEBI ID: CHEBI:17196

PubChem ID: 6267

Chemical Formula: C4H8N2O3

Smiles: C([C@@H](C(=O)O)N)C(=O)N

InChI: InChI=1S/C4H8N2O3/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H2,6,7)(H,8,9)/t2-/m0/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
13 Molecular Structure

Aspartate

CHEBI ID: CHEBI:17053

PubChem ID: 5960

Chemical Formula: C4H7NO4

Smiles: C([C@@H](C(=O)O)N)C(=O)O

InChI: InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
14 Molecular Structure

Betaine

CHEBI ID: CHEBI:17750

PubChem ID: 247

Chemical Formula: C5H11NO2

Smiles: C[N+](C)(C)CC(=O)[O-]

InChI: InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
15 Molecular Structure

Carnitine

CHEBI ID: CHEBI:17126

PubChem ID: 288

Chemical Formula: C7H15NO3

Smiles: C[N+](C)(C)CC(CC(=O)[O-])O

InChI: InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
16 Molecular Structure

Choline

CHEBI ID: CHEBI:15354

PubChem ID: 305

Chemical Formula: C5H14NO+

Smiles: C[N+](C)(C)CCO

InChI: InChI=1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
17 Molecular Structure

Citrate

CHEBI ID: CHEBI:16947

PubChem ID: 31348

Chemical Formula: C6H5O7-3

Smiles: C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O

InChI: InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/p-3

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
18 Molecular Structure

Creatine

CHEBI ID: CHEBI:16919

PubChem ID: 586

Chemical Formula: C4H9N3O2

Smiles: CN(CC(=O)O)C(=N)N

InChI: InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
19 Molecular Structure

Creatinine

CHEBI ID: CHEBI:16737

PubChem ID: 588

Chemical Formula: C4H7N3O

Smiles: CN1CC(=O)N=C1N

InChI: InChI=1S/C4H7N3O/c1-7-2-3(8)6-4(7)5/h2H2,1H3,(H2,5,6,8)

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
20 Molecular Structure

Dimethyl sulfone

CHEBI ID: CHEBI:9349

PubChem ID: 6213

Chemical Formula: C2H6O2S

Smiles: CS(=O)(=O)C

InChI: InChI=1S/C2H6O2S/c1-5(2,3)4/h1-2H3

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
21 Molecular Structure

Dimethylamine

CHEBI ID: CHEBI:17170

PubChem ID: 674

Chemical Formula: C2H7N

Smiles: CNC

InChI: InChI=1S/C2H7N/c1-3-2/h3H,1-2H3

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
22 Molecular Structure

Formate

CHEBI ID: CHEBI:15740

PubChem ID: 283

Chemical Formula: CHO2-

Smiles: C(=O)[O-]

InChI: InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)/p-1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
23 Molecular Structure

Glucose

CHEBI ID: CHEBI:4167

PubChem ID: 5793

Chemical Formula: C6H12O6

Smiles: C([C@@H]1[C@H]([C@@H]([C@H](C(O1)O)O)O)O)O

InChI: InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6?/m1/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
24 Molecular Structure

Glutamate

CHEBI ID: CHEBI:16015

PubChem ID: 33032

Chemical Formula: C5H9NO4

Smiles: C(CC(=O)O)[C@@H](C(=O)O)N

InChI: InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
25 Molecular Structure

Glutamine

CHEBI ID: CHEBI:18050

PubChem ID: 5961

Chemical Formula: C5H10N2O3

Smiles: C(CC(=O)N)[C@@H](C(=O)O)N

InChI: InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
26 Molecular Structure

Glycerol

CHEBI ID: CHEBI:17754

PubChem ID: 753

Chemical Formula: C3H8O3

Smiles: C(C(CO)O)O

InChI: InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
27 Molecular Structure

Glycine

CHEBI ID: CHEBI:15428

PubChem ID: 750

Chemical Formula: C2H5NO2

Smiles: C(C(=O)O)N

InChI: InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
28 Molecular Structure

Histidine

CHEBI ID: CHEBI:15971

PubChem ID: 6274

Chemical Formula: C6H9N3O2

Smiles: C1=C(NC=N1)C[C@@H](C(=O)O)N

InChI: InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
29 Molecular Structure

Hypoxanthine

CHEBI ID: CHEBI:17368

PubChem ID: 135398638

Chemical Formula: C5H4N4O

Smiles: C1=NC2=C(N1)C(=O)NC=N2

InChI: InChI=1S/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
30 Molecular Structure

Isoleucine

CHEBI ID: CHEBI:17191

PubChem ID: 6306

Chemical Formula: C6H13NO2

Smiles: CC[C@H](C)[C@@H](C(=O)O)N

InChI: InChI=1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
31 Molecular Structure

Lactate

CHEBI ID: CHEBI:24996

PubChem ID: 91435

Chemical Formula: C3H5O3-

Smiles: CC(C(=O)[O-])O

InChI: InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/p-1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
32 Molecular Structure

Leucine

CHEBI ID: CHEBI:24996

PubChem ID: 91435

Chemical Formula: C3H5O3-

Smiles: CC(C(=O)[O-])O

InChI: InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/p-1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
33 Molecular Structure

Lysine

CHEBI ID: CHEBI:18019

PubChem ID: 5962

Chemical Formula: C6H14N2O2

Smiles: C(CCN)C[C@@H](C(=O)O)N

InChI: InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/t5-/m0/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
34 Molecular Structure

Malonate

CHEBI ID: CHEBI:30794

PubChem ID: 867

Chemical Formula: C3H4O4

Smiles: C(C(=O)O)C(=O)O

InChI: InChI=1S/C3H4O4/c4-2(5)1-3(6)7/h1H2,(H,4,5)(H,6,7)

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
35 Molecular Structure

N,N-Dimethylglycine

CHEBI ID: CHEBI:17724

PubChem ID: 673

Chemical Formula: C4H9NO2

Smiles: CN(C)CC(=O)O

InChI: InChI=1S/C4H9NO2/c1-5(2)3-4(6)7/h3H2,1-2H3,(H,6,7)

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
36 Molecular Structure

Phenylalanine

CHEBI ID: CHEBI:17295

PubChem ID: 6140

Chemical Formula: C9H11NO2

Smiles: C1=CC=C(C=C1)C[C@@H](C(=O)O)N

InChI: InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
37 Molecular Structure

Proline

CHEBI ID: CHEBI:17203

PubChem ID: 145742

Chemical Formula: C5H9NO2

Smiles: C1C[C@H](NC1)C(=O)O

InChI: InChI=1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m0/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
38 Molecular Structure

Pyruvate

CHEBI ID: CHEBI:15361

PubChem ID: 107735

Chemical Formula: C3H3O3-

Smiles: CC(=O)C(=O)[O-]

InChI: InChI=1S/C3H4O3/c1-2(4)3(5)6/h1H3,(H,5,6)/p-1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
39 Molecular Structure

Succinate

CHEBI ID: CHEBI:30031

PubChem ID: 160419

Chemical Formula: C4H4O4-2

Smiles: C(CC(=O)[O-])C(=O)[O-]

InChI: InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8)/p-2

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
40 Molecular Structure

Threonine

CHEBI ID: CHEBI:16857

PubChem ID: 6288

Chemical Formula: C4H9NO3

Smiles: C[C@H]([C@@H](C(=O)O)N)O

InChI: InChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
41 Molecular Structure

Trimethylamine

CHEBI ID: CHEBI:18139

PubChem ID: 1146

Chemical Formula: C3H9N

Smiles: CN(C)C

InChI: InChI=1S/C3H9N/c1-4(2)3/h1-3H3

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
42 Molecular Structure

Trimethylamine N-oxide

CHEBI ID: CHEBI:15724

PubChem ID: 1145

Chemical Formula: C3H9NO

Smiles: C[N+](C)(C)[O-]

InChI: InChI=1S/C3H9NO/c1-4(2,3)5/h1-3H3

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
43 Molecular Structure

Tyrosine

CHEBI ID: CHEBI:17895

PubChem ID: 6057

Chemical Formula: C9H11NO3

Smiles: C1=CC(=CC=C1C[C@@H](C(=O)O)N)O

InChI: InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
44 Molecular Structure

Valine

CHEBI ID: CHEBI:16414

PubChem ID: 6287

Chemical Formula: C5H11NO2

Smiles: CC(C)[C@@H](C(=O)O)N

InChI: InChI=1S/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8)/t4-/m0/s1

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
45 Molecular Structure

cis-Aconitate

CHEBI ID: CHEBI:32805

PubChem ID: 643757

Chemical Formula: C6H6O6

Smiles: C(/C(=C/C(=O)O)/C(=O)O)C(=O)O

InChI: InChI=1S/C6H6O6/c7-4(8)1-3(6(11)12)2-5(9)10/h1H,2H2,(H,7,8)(H,9,10)(H,11,12)/b3-1-

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA
46 Molecular Structure

myo-Inositol

CHEBI ID: CHEBI:17268

PubChem ID: 516572213

Chemical Formula: C6H12O6

Smiles: O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O

InChI: InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H/t1-,2-,3-,4+,5-,6-

Mass to charge: NA

Retention Time: NA

Chemical Shift: NA